Product Image

NeuroQ

LifeSeasons
4.1
★ ★ ★ ★ ★
(1981 ratings)
Ginkgo
Turmeric 250 mg
Propolis 75 mg
Product Image
Score66
Best suited to broad, stimulant-light cognitive support rather than turmeric alone. Uncertain curcuminoid yield is the central trade-off.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:
Brain Health
Cognitive Support
Mental Focus
Productivity Boost

Score 66

Best suited to broad, stimulant-light cognitive support rather than turmeric alone. Uncertain curcuminoid yield is the central trade-off.
How scoring works
$69.95($2.33 per serving)
iHerb
$ 69.95
Pure Formulas
$ 69.95
Amazon
$ 69.95
Report prices

Analysis

The serving provides 250 mg turmeric extract. Multi-ingredient cognitive formula is best considered by its disclosed active yield rather than the product name alone.

Ginkgo, phosphatidylserine, gotu kola, coffee fruit, turmeric, and propolis cover several cognitive pathways. The formula is much better aligned with gradual brain and focus support than targeted vision or turmeric use.

The serving is expensive when judged only as turmeric, ginkgo, or propolis. Its value depends on wanting the full cognitive blend and accepting incomplete extract-standardization detail.

Who is it for
  • Broad, stimulant-light cognitive support rather than turmeric alone
  • People who prefer a two-capsule serving
  • Users who want the full combination rather than turmeric alone
Best for
  • Broad cognitive support
  • Simple daily botanical use
  • Capsule or tablet convenience

Pros

  • 250 mg turmeric extract is clearly listed
  • Simple serving format is easy to use
  • The two-capsule serving supports a clear use case

Cons

  • The turmeric and ginkgo marker percentages are not fully disclosed
  • No dedicated turmeric absorption system is identified
  • Broader blend reduces value for turmeric-only use

Warnings

  • Ginkgo and turmeric may increase bleeding risk with anticoagulant or antiplatelet medicines.
  • Propolis may be unsuitable for people with bee-product allergies.
  • The phosphatidylserine source is soy lecithin, which matters for people avoiding soy.

Nutrient quality

74 High impact

Ginkgo marker groups, curcuminoids, phosphatidylserine, and named extracts provide reasonable form quality, though marker percentages are missing. Ginkgo, turmeric, gotu kola, and phosphatidylserine have useful amounts for a broad cognitive formula, while ginkgo and turmeric may increase bleeding risk with anticoagulant or antiplatelet medicines, while propolis is unsuitable for bee-product allergy.

Ingredient transparency

74 High impact

Every active has an amount, but extract marker percentages and ginkgo purity limits are not disclosed. Serving totals are apparent, but full directions and inactive ingredients are not supplied.

Customer satisfaction

62 Moderate impact

The supplied average rating is moderately positive. A large rating base gives the average good reliability, while complaint and firsthand experience details are unavailable.

Value for money

48 Lower impact

Quality and disclosure gaps weaken the asking position. The serving value is weak within the category.

Report analysis

Goals

Brain Health
Brain Health
Impact
Highest effect
A Goal FitB+ Strength of SupportA- CoverageB+ Formula Quality

Ginkgo, phosphatidylserine, gotu kola, turmeric, and coffee fruit provide broad support for circulation, cell membranes, and oxidative resilience. The main cognitive actives are clearly disclosed at useful amounts.

Missing ginkgo marker percentages and limited standardization details reduce certainty about active quality. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
High effect
B Goal FitB Strength of SupportB CoverageB Formula Quality

The formula is well aligned with cognitive support through ginkgo for cerebral circulation and phosphatidylserine for brain-cell membranes. Gotu kola, turmeric, and coffee fruit broaden the approach, although their cognitive roles are less firmly established from the supplied details.

The ginkgo amount is within a commonly used range, but marker percentages and ginkgolic-acid purity are not disclosed. Ginkgo and turmeric may increase bleeding risk for people using anticoagulant or antiplatelet medicines, while propolis may be unsuitable for people with bee-product allergies.

Study evidence
Ginkgo Supportive 87 studies
Mental Focus
Mental Focus
Impact
High effect
B- Goal FitB- Strength of SupportC+ CoverageB- Formula Quality

Ginkgo and phosphatidylserine provide plausible support for attention, circulation, and neuronal membranes. The evidence is more relevant to gradual cognitive support than a rapid lift in alertness.

The ginkgo amount fits a common range and phosphatidylserine is present at a useful introductory amount. Missing ginkgo marker percentages limit quality confidence, and ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies
Productivity Boost
Productivity Boost
Impact
High effect
B- Goal FitB- Strength of SupportB- CoverageB- Formula Quality

Ginkgo and phosphatidylserine support memory and mental clarity, while gotu kola and coffee fruit add broader cognitive intent. The formula is stimulant-light and better suited to steady support than immediate alertness.

Core amounts are practical, but ginkgo marker percentages and coffee-fruit standardization are not disclosed. Ginkgo may increase bleeding risk when used with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies

Ingredients

IngredientAmount per serving
Gotu Kola aerial extract
250 mg
Turmeric rhizome extract (Curcuminoids)
 250 mg
Ginkgo leaf extract (Flavone Glycosides, Terpene Lactones)
 120 mg
Phosphatidylserine (non-GMO Soy Lecithin)
 100 mg
Coffee fruit extract
100 mg
Propolis extract
75 mg
Gluten Free Adults 18–50 Dairy Free Vegetarian
Report overview
Ginkgo (Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore61
D- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The extract amount fits the commonly used daily range and names both key marker groups. Marker percentages and ginkgolic-acid purity are not disclosed. The serving is costly for its documented ginkgo quality, even as part of a broader nutrient formula. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

View ingredientView products
Turmeric (Curcuminoids) · 250 mg OverallScore37
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value

A moderate curcuminoid dose is clearly identified. The formula lacks a standardization percentage and a qualifying absorption system. Its very high serving cost makes it poor value for turmeric alone.

View ingredientView products
Propolis · 75 mg OverallScore36
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyF Value

The propolis extract is a minor part of the formula and lacks source, concentration, and active-marker details. Its actual weight is disclosed, and no artificial capsule additive is listed in the supplied data. The high cost produces poor propolis value, while ginkgo and turmeric may increase bleeding risk for people using anticoagulant or antiplatelet medicines.

View ingredientView products
Loading alternative details
67 Value

Mushroom Mental Clarity & Focus

Kirkman
This is the only supplied candidate permitted for the product, and its lower serving cost combines methylcobalamin with lion’s mane, bacopa, ginkgo, turmeric, cordyceps, and PQQ. Most botanical amounts are light or lack potency markers, while ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  2. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledMental Focus forGinkgo
  3. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  4. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  5. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  6. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  7. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  8. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  9. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  10. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  11. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  12. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.
    Hashiguchi M; Ohta Y; Shimizu M; Maruyama J; Mochizuki M · Journal of pharmaceutical health care and sciences · 2016
    Meta-analysis2,381 participants13 studies pooledCognitive Support Brain Health forGinkgo
  13. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  14. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  15. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  16. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  17. Ginkgo biloba for cognitive impairment and dementia.
    Birks J; Grimley Evans J · The Cochrane database of systematic reviews · 2009
    Meta-analysis2,016 participants36 studies pooledMental Focus forGinkgo
  18. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  19. EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis.
    Zhan M; Sun L; Liu J; Zeng Z; Shen W; Li H; Wang Y; Han F; Shi J; Zeng X; Lu X; Zhang Y; Liao X · Oxidative medicine and cellular longevity · 2022
    Meta-analysis2,019 participants23 studies pooledCognitive Support Brain Health forGinkgo
  20. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsMental Focus Productivity Boost forGinkgo
  21. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  22. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults.
    Kennedy DO; Scholey AB; Wesnes KA · Physiology & behavior · 2002
    Randomized trial20 participantsMental Focus forGinkgo
  23. Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction-meta-analysis of pooled data from randomised clinical trials.
    Feng JX; Zheng MQ; Tian X; Zimmermann A; Wang AX; Meng X · Frontiers in neurology · 2026
    Meta-analysis488 participants4 studies pooledBrain Health forGinkgo
  24. Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence.
    Sarris J; Kean J; Schweitzer I; Lake J · Complementary therapies in medicine · 2012
    Systematic review16 studies pooledMental Focus forGinkgo
  25. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  26. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  27. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  28. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  29. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  30. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  31. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo